A
$ Value
$0
Shares
51,804
Price
$0
Filed
Jun 25
Insider
Name
TETLOW SHARON
Title
—
CIK
0001328565
Roles
Director
Transaction Details
Transaction Date
2025-06-23
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
51,804
Footnotes
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs"). | The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting, | The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.
Filing Info
TETLOW SHARON's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-23 | GPCR | A | $0 |
Other Insiders at GPCR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FMR LLC | — | $961K | 2026-04-14 |
|
Stevens Raymond C
CHIEF EXECUTIVE OFFICER
|
— | — | 2026-03-19 |
|
Lang Matthew
COO & GC
|
— | — | 2026-04-15 |
|
Hall Ashley
Chief Development Officer
|
— | — | 2026-03-19 |
|
Yoon Jun
CHIEF FINANCIAL OFFICER
|
— | — | 2026-03-19 |
|
Lin Xichen
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-03-19 |
|
Ma Yingli
CHIEF TECHNOLOGY OFFICER
|
— | — | 2026-03-19 |
|
Coll Crespo Blas
CHIEF MEDICAL OFFICER
|
— | — | 2026-03-19 |